Physician profile
David Anwar
NPI 1609196377
$12,482.84
in general payments reported to CMS, 2019-2025
56 companies · $2,649 in 2025
The $2,649 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,899 · 2020: $488 · 2021: $790 · 2022: $1,843 · 2023: $2,336 · 2024: $2,477 · 2025: $2,649.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,373 · Education: $88.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,373.41 |
| Education | $88.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,239.66 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $961.14 | 2019-2025 | Camzyos, Eliquis |
| Abiomed | $946.77 | 2019-2025 | Impella |
| Abbott Laboratories | $775.00 | 2019-2024 | Aveir, Jot Dx |
| Amgen INC. | $710.42 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $672.19 | 2022-2025 | Watchman Flx, Bodyguardian, Lux-Dx Insertable Cardiac Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $576.46 | 2019-2025 | Lifevest |
| Pfizer INC. | $501.44 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $480.66 | 2019-2025 | Uptravi, Opsumit |
| Janssen Pharmaceuticals, INC | $462.98 | 2019-2024 | Xarelto |
| Irhythm Technologies, INC. | $429.87 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Merck Sharp & Dohme LLC | $399.61 | 2021-2025 | Verquvo, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $389.32 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $357.95 | 2019-2025 | Farxiga, Lynparza |
| Edwards Lifesciences Corporation | $357.73 | 2024-2025 | Pascal, Sapien 3 Ultra Resilia |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $308.61 | 2025 | |
| Acist Medical Systems, INC. | $251.29 | 2022-2023 | |
| Alnylam Pharmaceuticals INC. | $211.93 | 2024-2025 | Amvuttra, Onpattro |
| Amarin Pharma, INC. | $196.63 | 2019-2023 | |
| Esperion Therapeutics, INC. | $163.56 | 2021-2025 | Nexletol |
| Philips North America LLC | $163.24 | 2019-2025 | Lm Accessories, (5044) Mcot |
| Cook Medical LLC | $162.43 | 2023-2025 | Zilver Ptx |
| Veryan Medical Incorporated | $123.28 | 2022 | |
| Medtronic, INC. | $118.87 | 2021-2025 | Micra |
| Braemar Manufacturing, LLC | $100.63 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $94.38 | 2019-2024 | Evkeeza |
| Cvrx, INC. | $89.85 | 2022-2025 | Barostim Neo System |
| Kiniksa Pharmaceuticals, Ltd. | $83.68 | 2021-2023 | Arcalyst |
| Silk Road Medical, INC. | $78.40 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Kestra Medical Technology Services, INC. | $73.21 | 2024 | Assure Wcd |
| Novo Nordisk INC | $69.09 | 2024-2025 | Wegovy |
| W. L. Gore & Associates, INC. | $69.07 | 2021-2022 | |
| Bridgebio Pharma, INC. | $66.74 | 2025 | Attruby |
| Lantheus Medical Imaging, INC. | $63.67 | 2021-2024 | |
| Integra Lifesciences Corporation | $60.88 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Tactile Systems Technology INC | $52.90 | 2025 | Flexitouch Plus, Nimbl |
| United Therapeutics Corporation | $50.02 | 2023-2025 | Tyvaso, Tyvaso, Orenitram |
| Osprey Medical INC | $49.00 | 2019 | |
| Scpharmaceuticals INC. | $48.83 | 2024-2025 | |
| Akcea Therapeutics, INC. | $46.43 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.14 | 2022-2023 | |
| Angiodynamics, INC. | $41.61 | 2023 | Auryon Laser System 100-120 Vac |
| Biogen, INC. | $41.01 | 2024-2025 | Skyclarys |
| Imperative Care, INC | $39.94 | 2025 | Symphony Catheter, Prodigy Twist |
| Cardiovascular Systems INC. | $35.33 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $32.57 | 2024 | Arcalyst |
| Daiichi Sankyo INC. | $30.30 | 2022-2023 | Injectafer |
| Genzyme Corporation | $29.44 | 2021-2022 | |
| Ionis Pharmaceuticals, INC. | $19.00 | 2025 | Tryngolza |
| Csl Behring | $18.95 | 2019 | |
| Atricure, INC. | $18.84 | 2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Shockwave Medical, INC | $17.00 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Corcept Therapeutics | $15.74 | 2025 | Korlym |
| Ge Healthcare | $15.38 | 2019 | |
| Astellas Pharma US INC | $14.76 | 2021 | |
| Arbor Pharmaceuticals, INC. | $11.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Anwar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.